Angirid MR 35 mg (Tablet (Modified Release))
Unit Price: ৳ 10.00 (6 x 10: ৳ 600.00)
Strip Price: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Trimetazidine dihydrochloride |
Company | Acme laboratories ltd |
Indications
- Symptomatic treatment of stable angina pectoris
- Add-on therapy for angina pectoris
Pharmacology
- First 3-keto acyl CoA thiolase inhibitor
- Metabolic anti-ischemic agent
- Inhibits fatty acid pathway
- Enhances glucose pathway efficiency
- Prevents angina pectoris
Dosage & Administration
- Recommended dose of 35 mg twice daily or 20 mg thrice daily
- Should be taken during meals
- Assess treatment benefit after three months
Interaction
- No reported drug interactions
- No interaction with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents, or digitalis preparation
Contraindications
- Hypersensitivity to active substance or excipients
- Parkinson’s disease, parkinsonian symptoms, tremors
- Restless legs movement disorders
- Severe renal impairment
Side Effects
- Dizziness
- Headache
- Abdominal pain
- Diarrhoea
- Dyspepsia
- Nausea
- Vomiting
- Rash
- Pruritus
- Urticaria
- Asthenia
Pregnancy & Lactation
- No data on use in pregnant women
- Preferable to avoid use during pregnancy
- Unknown excretion in human milk
- Risk to newborns/infants cannot be excluded
- Not to be used during breastfeeding
Precautions & Warnings
- Not a curative treatment for angina attacks
- Not an initial treatment for unstable angina pectoris
- Not a treatment for myocardial infarction
Therapeutic Class
- Other Anti-anginal & Anti-ischaemic drugs
Storage Conditions
- Keep in dry place
- Keep away from light and heat
- Keep out of reach of children